Tema ETFs’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.48M Buy
164,530
+9,933
+6% +$570K 0.31% 75
2026
Q1
$9.38M Buy
154,597
+26,838
+21% +$1.56M 0.63% 48
2025
Q4
$6.89M Buy
127,759
+25,521
+25% +$1.23M 0.53% 56
2025
Q3
$4.61M Buy
102,238
+25,997
+34% +$1.21M 0.38% 81
2025
Q2
$3.53M Buy
76,241
+1,191
+2% +$58.5K 0.94% 38
2025
Q1
$4.58M Buy
+75,050
New +$4.37M 1.37% 18

Other funds holding BMY

Tema ETFs's BMY Position: Q2 2026 in Review

Tema ETFs increased its Bristol-Myers Squibb (BMY) stake by 6.4% in Q2 2026, buying an estimated $570K and bringing the position to 164,530 shares worth $9.48M. The position accounts for 0.31% of the portfolio, ranked #75.

Tema ETFs first reported a position in BMY in Q1 2025 and has held it in 6 quarters since. 814 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Tema ETFs held 164,530 shares of Bristol-Myers Squibb worth $9.48M as of Q2 2026.
  • Tema ETFs bought 9,933 Bristol-Myers Squibb shares in Q2 2026, an estimated $570K.
  • Bristol-Myers Squibb made up 0.31% of Tema ETFs's portfolio in Q2 2026, its #75 holding.
  • Tema ETFs first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 6 quarters since.
  • 814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.